Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 68

1.

Targeting root ion uptake kinetics to increase plant productivity and nutrient use efficiency.

Griffiths M, York L.

Plant Physiol. 2020 Feb 6. pii: pp.01496.2019. doi: 10.1104/pp.19.01496. [Epub ahead of print]

2.

Clinical Outcomes Following the Use of Archived Proviral HIV-1 DNA Genotype to Guide Antiretroviral Therapy Adjustment.

Ellis KE, Nawas GT, Chan C, York L, Fisher J, Connick E, Zangeneh TT.

Open Forum Infect Dis. 2019 Dec 14;7(1):ofz533. doi: 10.1093/ofid/ofz533. eCollection 2020 Jan.

3.

Economic evaluation of meningococcal vaccines: considerations for the future.

Christensen H, Al-Janabi H, Levy P, Postma MJ, Bloom DE, Landa P, Damm O, Salisbury DM, Diez-Domingo J, Towse AK, Lorgelly PK, Shah KK, Hernandez-Villafuerte K, Smith V, Glennie L, Wright C, York L, Farkouh R.

Eur J Health Econ. 2019 Nov 21. doi: 10.1007/s10198-019-01129-z. [Epub ahead of print]

PMID:
31754924
4.

Healthy Spaces: Legal Tools, Innovations, and Partnerships.

Brady RA, Stettner JL, York L.

J Law Med Ethics. 2019 Jun;47(2_suppl):27-30. doi: 10.1177/1073110519857311.

PMID:
31298119
5.
6.

Persistence and 4-year boosting of the bactericidal response elicited by two- and three-dose schedules of MenB-FHbp: A phase 3 extension study in adolescents.

Vesikari T, Østergaard L, Beeslaar J, Absalon J, Eiden JJ, Jansen KU, Jones TR, Harris SL, Maansson R, Munson S, O'Neill RE, York LJ, Perez JL.

Vaccine. 2019 Mar 14;37(12):1710-1719. doi: 10.1016/j.vaccine.2018.11.073. Epub 2019 Feb 12.

PMID:
30770221
7.
8.

Meningococcal disease in adolescents and young adults: a review of the rationale for prevention through vaccination.

Burman C, Serra L, Nuttens C, Presa J, Balmer P, York L.

Hum Vaccin Immunother. 2019;15(2):459-469. doi: 10.1080/21645515.2018.1528831. Epub 2018 Oct 29. Review.

9.

Meningococcal Group A, C, W, and Y Tetanus Toxoid Conjugate Vaccine: A Review of Clinical Data in Adolescents.

Serra LC, York LJ, Balmer P, Webber C.

J Adolesc Health. 2018 Sep;63(3):269-279. doi: 10.1016/j.jadohealth.2018.05.012. Review.

PMID:
30236996
10.

Optimal use of meningococcal serogroup B vaccines: moving beyond outbreak control.

Balmer P, York LJ.

Ther Adv Vaccines Immunother. 2018 Jun 21;6(3):49-60. doi: 10.1177/2515135518781757. eCollection 2018 May. Review.

11.

Rice actin binding protein RMD controls crown root angle in response to external phosphate.

Huang G, Liang W, Sturrock CJ, Pandey BK, Giri J, Mairhofer S, Wang D, Muller L, Tan H, York LM, Yang J, Song Y, Kim YJ, Qiao Y, Xu J, Kepinski S, Bennett MJ, Zhang D.

Nat Commun. 2018 Jun 11;9(1):2346. doi: 10.1038/s41467-018-04710-x.

12.

From research to licensure and beyond: clinical development of MenB-FHbp, a broadly protective meningococcal B vaccine.

Perez JL, Absalon J, Beeslaar J, Balmer P, Jansen KU, Jones TR, Harris S, York LJ, Jiang Q, Radley D, Anderson AS, Crowther G, Eiden JJ.

Expert Rev Vaccines. 2018 Jun;17(6):461-477. doi: 10.1080/14760584.2018.1483726. Epub 2018 Jun 22. Review.

PMID:
29883226
13.

Clinical data supporting a 2-dose schedule of MenB-FHbp, a bivalent meningococcal serogroup B vaccine, in adolescents and young adults.

Beeslaar J, Absalon J, Balmer P, Srivastava A, Maansson R, York LJ, Perez JL.

Vaccine. 2018 Jun 27;36(28):4004-4013. doi: 10.1016/j.vaccine.2018.05.060. Epub 2018 Jun 1. Review.

PMID:
29861182
14.

Impact of meningococcal vaccination on carriage and disease transmission: A review of the literature.

Balmer P, Burman C, Serra L, York LJ.

Hum Vaccin Immunother. 2018 May 4;14(5):1118-1130. doi: 10.1080/21645515.2018.1454570. Epub 2018 May 9. Review.

15.

A Review of Meningococcal Disease and Vaccination Recommendations for Travelers.

Serra LC, York LJ, Gamil A, Balmer P, Webber C.

Infect Dis Ther. 2018 Jun;7(2):219-234. doi: 10.1007/s40121-018-0196-z. Epub 2018 Mar 17. Review.

16.

Vaccination strategies for the prevention of meningococcal disease.

Vuocolo S, Balmer P, Gruber WC, Jansen KU, Anderson AS, Perez JL, York LJ.

Hum Vaccin Immunother. 2018 May 4;14(5):1203-1215. doi: 10.1080/21645515.2018.1451287. Epub 2018 Apr 13. Review.

17.

Phenotyping Crop Root Crowns: General Guidance and Specific Protocols for Maize, Wheat, and Soybean.

York LM.

Methods Mol Biol. 2018;1761:23-32. doi: 10.1007/978-1-4939-7747-5_2.

PMID:
29525946
18.

A Bivalent Meningococcal B Vaccine in Adolescents and Young Adults.

Ostergaard L, Vesikari T, Absalon J, Beeslaar J, Ward BJ, Senders S, Eiden JJ, Jansen KU, Anderson AS, York LJ, Jones TR, Harris SL, O'Neill R, Radley D, Maansson R, Prégaldien JL, Ginis J, Staerke NB, Perez JL; B1971009 and B1971016 Trial Investigators.

N Engl J Med. 2017 Dec 14;377(24):2349-2362. doi: 10.1056/NEJMoa1614474.

19.

Telephone care co-ordination for tobacco cessation: randomised trials testing proactive versus reactive models.

Sherman SE, Krebs P, York LS, Cummins SE, Kuschner W, Guvenc-Tuncturk S, Zhu SH.

Tob Control. 2018 Jan;27(1):78-82. doi: 10.1136/tobaccocontrol-2016-053327. Epub 2017 Feb 11.

PMID:
28190003
20.

A deterministic evaluation of heat stress mitigation and feed cost under climate change within the smallholder dairy sector.

York L, Heffernan C, Rymer C, Panda N.

Animal. 2017 May;11(5):900-909. doi: 10.1017/S1751731116002706. Epub 2016 Dec 28.

PMID:
28027721
21.

Characteristics of a new meningococcal serogroup B vaccine, bivalent rLP2086 (MenB-FHbp; Trumenba®).

Gandhi A, Balmer P, York LJ.

Postgrad Med. 2016 Aug;128(6):548-56. doi: 10.1080/00325481.2016.1203238. Epub 2016 Jul 7. Review.

PMID:
27467048
22.
23.

The holistic rhizosphere: integrating zones, processes, and semantics in the soil influenced by roots.

York LM, Carminati A, Mooney SJ, Ritz K, Bennett MJ.

J Exp Bot. 2016 Jun;67(12):3629-43. doi: 10.1093/jxb/erw108. Epub 2016 Mar 14. Review.

PMID:
26980751
25.

A phase 3, randomized, active-controlled study to assess the safety and tolerability of meningococcal serogroup B vaccine bivalent rLP2086 in healthy adolescents and young adults.

Ostergaard L, Lucksinger GH, Absalon J, Beeslaar J, Eiden J, Jansen KU, York LJ, Quinn A, Graversen ME, Perez JL.

Vaccine. 2016 Mar 14;34(12):1465-71. doi: 10.1016/j.vaccine.2016.01.044. Epub 2016 Feb 1.

26.

Immunogenicity, Tolerability and Safety in Adolescents of Bivalent rLP2086, a Meningococcal Serogroup B Vaccine, Coadministered with Quadrivalent Human Papilloma Virus Vaccine.

Senders S, Bhuyan P, Jiang Q, Absalon J, Eiden JJ, Jones TR, York LJ, Jansen KU, O'Neill RE, Harris SL, Ginis J, Perez JL.

Pediatr Infect Dis J. 2016 May;35(5):548-54. doi: 10.1097/INF.0000000000001072.

PMID:
26835974
27.

Immunogenicity, Safety, and Tolerability of Bivalent rLP2086 Meningococcal Group B Vaccine Administered Concomitantly With Diphtheria, Tetanus, and Acellular Pertussis and Inactivated Poliomyelitis Vaccines to Healthy Adolescents.

Vesikari T, Wysocki J, Beeslaar J, Eiden J, Jiang Q, Jansen KU, Jones TR, Harris SL, O'Neill RE, York LJ, Perez JL.

J Pediatric Infect Dis Soc. 2016 Jun;5(2):180-7. doi: 10.1093/jpids/piv064. Epub 2016 Jan 23.

28.

Immunogenicity, safety, and tolerability of the meningococcal serogroup B bivalent rLP2086 vaccine in adult laboratory workers.

Reiner DM, Bhuyan P, Eiden JJ, Ginis J, Harris S, Jansen KU, Jiang Q, Jones TR, O'Neill RE, York LJ, Perez JL.

Vaccine. 2016 Feb 3;34(6):809-13. doi: 10.1016/j.vaccine.2015.12.016. Epub 2015 Dec 19.

PMID:
26707218
29.

Meningococcal Serogroup B Bivalent rLP2086 Vaccine Elicits Broad and Robust Serum Bactericidal Responses in Healthy Adolescents.

Vesikari T, Østergaard L, Diez-Domingo J, Wysocki J, Flodmark CE, Beeslaar J, Eiden J, Jiang Q, Jansen KU, Jones TR, Harris SL, O'Neill RE, York LJ, Crowther G, Perez JL.

J Pediatric Infect Dis Soc. 2016 Jun;5(2):152-60. doi: 10.1093/jpids/piv039. Epub 2015 Aug 4.

30.

A Qualitative Evaluation of Web-Based Cancer Care Quality Improvement Toolkit Use in the Veterans Health Administration.

Bowman C, Luck J, Gale RC, Smith N, York LS, Asch S.

Qual Manag Health Care. 2015 Jul-Sep;24(3):147-61. doi: 10.1097/QMH.0000000000000063.

PMID:
26115063
31.
32.

Implementing a user-driven online quality improvement toolkit for cancer care.

Luck J, York LS, Bowman C, Gale RC, Smith N, Asch SM.

J Oncol Pract. 2015 May;11(3):e421-7. doi: 10.1200/JOP.2014.003012. Epub 2015 Apr 7.

PMID:
25852141
33.

Evolution of US maize (Zea mays L.) root architectural and anatomical phenes over the past 100 years corresponds to increased tolerance of nitrogen stress.

York LM, Galindo-Castañeda T, Schussler JR, Lynch JP.

J Exp Bot. 2015 Apr;66(8):2347-58. doi: 10.1093/jxb/erv074. Epub 2015 Mar 20.

34.

Silk hydrogels for sustained ocular delivery of anti-vascular endothelial growth factor (anti-VEGF) therapeutics.

Lovett ML, Wang X, Yucel T, York L, Keirstead M, Haggerty L, Kaplan DL.

Eur J Pharm Biopharm. 2015 Sep;95(Pt B):271-8. doi: 10.1016/j.ejpb.2014.12.029. Epub 2015 Jan 12.

PMID:
25592326
35.

Root foraging elicits niche complementarity-dependent yield advantage in the ancient 'three sisters' (maize/bean/squash) polyculture.

Zhang C, Postma JA, York LM, Lynch JP.

Ann Bot. 2014 Dec;114(8):1719-33. doi: 10.1093/aob/mcu191. Epub 2014 Oct 1.

36.

Image-based high-throughput field phenotyping of crop roots.

Bucksch A, Burridge J, York LM, Das A, Nord E, Weitz JS, Lynch JP.

Plant Physiol. 2014 Oct;166(2):470-86. doi: 10.1104/pp.114.243519. Epub 2014 Sep 3.

37.

Multimethod evaluation of the VA's peer-to-peer Toolkit for patient-centered medical home implementation.

Luck J, Bowman C, York L, Midboe A, Taylor T, Gale R, Asch S.

J Gen Intern Med. 2014 Jul;29 Suppl 2:S572-8. doi: 10.1007/s11606-013-2738-0.

38.

Online toolkits for metric-driven quality improvement: the Veterans Health Administration managed grassroots approach.

York L, Bruce B, Luck J, Bowman C, Midboe AM, Smith N, Elenes M, Girard J, Griffith D, Edwards G, Ahluwalia S, Zisser A, Asch S.

Jt Comm J Qual Patient Saf. 2013 Dec;39(12):561-9. No abstract available.

PMID:
24416947
39.

Integration of root phenes for soil resource acquisition.

York LM, Nord EA, Lynch JP.

Front Plant Sci. 2013 Sep 12;4:355. doi: 10.3389/fpls.2013.00355. eCollection 2013.

40.

A multi-country evaluation of Neisseria meningitidis serogroup B factor H-binding proteins and implications for vaccine coverage in different age groups.

Hoiseth SK, Murphy E, Andrew L, Vogel U, Frosch M, Hellenbrand W, Abad R, Vazquez JA, Borrow R, Findlow J, Taha MK, Deghmane AE, Caugant DA, Kriz P, Musilek M, Mayer LW, Wang X, Macneil JR, York L, Tan CY, Jansen KU, Anderson AS.

Pediatr Infect Dis J. 2013 Oct;32(10):1096-101. doi: 10.1097/INF.0b013e31829aa63b.

PMID:
23694830
41.

Direct detection of bacterial genomic DNA at sub-femtomolar concentrations using single molecule arrays.

Song L, Shan D, Zhao M, Pink BA, Minnehan KA, York L, Gardel M, Sullivan S, Phillips AF, Hayman RB, Walt DR, Duffy DC.

Anal Chem. 2013 Feb 5;85(3):1932-9. doi: 10.1021/ac303426b. Epub 2013 Jan 18.

PMID:
23331316
42.

Potential impact of the bivalent rLP2806 vaccine on Neisseria meningitidis carriage and invasive serogroup B disease.

Anderson AS, Hao L, Jiang Q, Harris SL, Jones TR, Perez JL, York L, Eiden J, Jansen KU.

Hum Vaccin Immunother. 2013 Mar;9(3):471-9. Epub 2012 Dec 18.

43.

Recurrent networks with short term synaptic depression.

York LC, van Rossum MC.

J Comput Neurosci. 2009 Dec;27(3):607-20. doi: 10.1007/s10827-009-0172-4. Epub 2009 Jul 4.

PMID:
19578989
44.

Nonalcoholic fatty liver disease and low-carbohydrate diets.

York LW, Puthalapattu S, Wu GY.

Annu Rev Nutr. 2009;29:365-79. doi: 10.1146/annurev-nutr-070208-114232. Review.

PMID:
19575599
45.

Comparing the tolerability and effectiveness of two treatment regimens in a smoking clinic.

Sherman SE, Aldana I, Estrada M, York L.

Mil Med. 2008 Jun;173(6):550-4.

PMID:
18595418
46.

The novel substituted pyrimidine, KP544, reduces motor deficits in the R6/2 transgenic mouse model of Huntington's disease.

Dey ND, Boersen AJ, Myers RA, York LR, Bombard MC, Lu M, Sandstrom MI, Hulce VD, Lescaudron L, Dunbar GL.

Restor Neurol Neurosci. 2007;25(5-6):485-92.

PMID:
18334766
47.

Trends in mode of delivery during 1984-2003: can they be explained by pregnancy and delivery complications?

O'Leary CM, de Klerk N, Keogh J, Pennell C, de Groot J, York L, Mulroy S, Stanley FJ.

BJOG. 2007 Jul;114(7):855-64. Epub 2007 May 15.

48.

Assessing the structure of smoking cessation care in the Veterans Health Administration.

Sherman SE, Yano EM, York LS, Lanto AB, Chernof BA, Mittman BS.

Am J Health Promot. 2006 May-Jun;20(5):313-8.

PMID:
16706001
49.

Interleukin-12 redirects murine immune responses to soluble or aluminum phosphate adsorbed HSV-2 glycoprotein D towards Th1 and CD4+ CTL responses.

Cooper D, Pride MW, Guo M, Cutler M, Mester JC, Nasar F, She J, Souza V, York L, Mishkin E, Eldridge J, Natuk RJ.

Vaccine. 2004 Nov 25;23(2):236-46.

PMID:
15531043
50.

The CA 125 gene: an extracellular superstructure dominated by repeat sequences.

O'Brien TJ, Beard JB, Underwood LJ, Dennis RA, Santin AD, York L.

Tumour Biol. 2001 Nov-Dec;22(6):348-66.

PMID:
11786729

Supplemental Content

Support Center